Oncimmune Holdings plc (ONC) Ordinary 1p
0.1p
(0.68%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.1p
(0.68%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.1p
(0.68%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
14.80p
15.08p
30.20p
£16.54 million
14.80p
15.00p
9.35p
n/a
1.00p (6.33%) Previous:
1.00p
42,510
n/a
15,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/08/2023 | 31/08/2022 |
|---|---|---|
| Revenue (£m) | 1.15 | 2.32 |
| Profit before tax (£m) | (5.93) | (6.58) |
| Adjusted EPS (p): | (8.47) | (7.91) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oncimmune secures three new contracts
31 October 2024 14:05
-
Oncimmune Holdings announces major recapitalisation
18 October 2024 11:09
-
Oncimmune secures additional contract with 'top ten global pharma' firm
2 September 2024 10:13
-
Holding(s) in Company
10 December 2024 15:36
-
Holding(s) in Company
4 December 2024 13:38
-
Holding(s) in Company
13 November 2024 17:06
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.